The Securities and Exchange Commission has kept Nasdaq's proposed bitcoin options in regulatory limbo, declining to act on the listing while it takes up a parallel request from CME Group to review how those contracts should be classified. The decision does not kill the product. It moves the fight over who has jurisdiction to a different doorstep.
**What the ruling actually says**
At the center is a jurisdictional argument with real consequences for every venue that wants to trade options on digital assets. CME contends the Nasdaq contracts are commodity option swaps, which would place them exclusively under the Commodity Futures Trading Commission's oversight rather than the SEC's. If that reading holds, the CFTC, not the SEC, becomes the gatekeeper for these products across all listing venues.
The SEC's move grants CME's request for review while leaving the Nasdaq application pending, a procedural posture that signals the agency has not reached a final view. Nothing in the action grants CME an exclusive right, and nothing forbids Nasdaq from eventually listing. The practical effect is a pause, not a rejection.
| Product | Venue | Status | Regulator in dispute |
| --- | --- | --- | --- |
| Bitcoin options | Nasdaq | On hold | SEC vs CFTC |
| Bitcoin options | CME | Under review | CFTC jurisdiction claim |
**Who the fight touches**
The underlying asset is bitcoin, trading near $62,869 with a roughly flat 24-hour move and a 7-day decline of 3.2%, per market data. The dispute reaches beyond Nasdaq. Any exchange that files a similar listing inherits the same question: whether an options contract on a commodity is a security product, because it sits on a stock exchange, or a commodity swap, because of what it is built on.
Market observers noted the distinction is not academic. If the CFTC route prevails, product oversight, margin rules, and surveillance live in one agency. If the SEC route prevails, the design and disclosure obligations of a securities market apply. The two regimes are not interchangeable, and the venue deciding your contract dictates which one you answer to.
**Why the timing matters**
The SEC granted CME review without imposing a deadline, which leaves Nasdaq and CME waiting on an agency schedule with no public clock. The options market for bitcoin has been the subject of repeated filings across venues, and an SEC decision here could set the template for the rest of them. A ruling in either direction resolves this product, while a continued hold leaves every pending application exposed to the same indeterminacy.
For desks reading the broader tape, the immediate market read is muted: BTC dominance sits at 56.2% and total market cap near $2.24 trillion, with the jurisdictional pause doing little to move the asset. The longer-term read is procedural. Until an agency publicly takes a position, the question of who regulates bitcoin options is settled by delay rather than by decision.
The next real signal will be a public SEC action on the review, a CFTC statement, or a Nasdaq refiling that forces the question. None of those events is calendared, which is itself the watchpoint. For traders, the product's fate now tracks an agency docket, not a price chart.